Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Joan Carles Galceran
39 years of experience • 1200+ treatments performed
Clinic is certified :
Sarcoma surgery in Spain typically costs from Price on request to Price on request . The final price depends on the tumor location, surgical technique, and the clinic tier. In the US, similar procedures cost around _price_compare_US_average_ on average. Spain offers savings of around _price_percent_discount_%. Standard costs usually include the surgical procedure, anesthesia, and initial post-operative hospital stay in cities like Barcelona, Madrid, and Pamplona.
Bookimed Expert Insight: Choosing Clinica Universidad de Navarra offers exceptional value with a 95% limb preservation rate. This center was the first Joint Commission International (JCI) accredited hospital in Spain. For pediatric cases, SJD Barcelona Children’s Hospital is a top-three European choice. They utilize advanced molecular medicine laboratories. These high-volume centers often provide better long-term outcomes for complex bone and soft tissue tumors.
Why do patients choose Spain for sarcoma surgery?
Access advanced Sarcoma surgery solutions in trusted clinics .
Day 1: Arrival
Day 2: Pre-operation
Day 3: Surgery
Day 4-7: Post-operation
Week 1-2: Rehabilitation
Week 3-6: Further Rehabilitation
Week 7 onwards: Final Result
Please note that each patient"s case is individual, and the timeline can vary based on the specifics of your condition and recovery rate.
Pediatric orthopedist-traumatologist, specializes in surgical oncology
15 years of experience
Specialist in Orthopedic Surgery and Traumatology – Dr. Mikel San Julian works at Clinica Universidad de Navarra.
Over 32 years of experience specializing in pediatric oncology – Dr. Lopez Ibor leads the Pediatric Hematology and Oncology Unit at HM Monteprincipe Hospital.
Dr. Joan Carles Galceran is a medical oncologist at the JCI-accredited Teknon Medical Center. He heads the Genitourinary and Sarcoma Unit at Vall d'Hebron University Hospital. Dr. Galceran specializes in non-surgical treatments for prostate, kidney, and bladder cancers. He is recognized as a top Spanish expert in genitourinary oncology.
Most patients require a multi-modal approach combining surgery with chemotherapy or radiation to effectively manage sarcoma and reduce recurrence. Spanish centers utilize advanced protocols, including intraarterial chemotherapy and limb preservation techniques, to maximize functional outcomes and survival rates for both adult and pediatric cases.
Bookimed Expert Insight: Data from Clinica Universidad de Navarra highlights a 74% bone sarcoma cure rate, which stems from their high-volume experience and integration of 3-Tesla MRI diagnostics. While surgery ranges from Price on request to Price on request , clinics in Madrid and Barcelona often include advanced technologies like CyberKnife to deliver precise radiation that protects surrounding healthy tissue.
Patient Consensus: Patients emphasize that surgery is rarely the only step, often involving months of pre-surgery cycles and adjuvant chemotherapy. Success is frequently tied to maintaining mental well-being while navigating these rigorous, long-term treatment schedules.
Limb-sparing surgery is a standard treatment for bone and soft-tissue sarcomas in Spain, accessible at Joint Commission International (JCI) accredited centers. Specialized oncology units achieve limb preservation rates up to 95% by removing tumors while salvaging critical nerves, blood vessels, and functional muscles.
Bookimed Expert Insight: Data from Clinica Universidad de Navarra highlights a significant performance gap, maintaining a 95% limb preservation rate specifically for sarcoma cases. While many centers offer limb-sparing options, choosing a facility that integrates intraarterial chemotherapy and dedicated orthopedic oncology increases the likelihood of avoiding amputation in complex cases.
Patient Consensus: Patients emphasize the necessity of intensive physical rehabilitation to regain mobility after receiving metal joint replacements. Most recommend seeking multidisciplinary teams that handle both the initial tumor removal and potential long-term implant revisions.